Brentuximab Vedotin
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance (NCT07178457) | Assistance Publique - Hôpitaux de Paris | 2025-11-01 |
| Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS (NCT06925555) | The First Affiliated Hospital with Nanjing Medical University | 2025-09-01 |
| Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment (NCT06563245) | Children's Cancer Group, China | 2024-09-25 |
Track Brentuximab Vedotin automatically
Every clearance here is in the API, with alerts when new ones post.